ECYT : Summary for Endocyte, Inc. - Yahoo Finance

U.S. Markets closed

Endocyte, Inc. (ECYT)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.21-0.04 (-1.78%)
At close: 4:00PM EDT
People also watch
ACRXINFIEPZMMACKCCXI
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close2.25
Open2.28
Bid0.00 x
Ask2.99 x 200
Day's Range2.21 - 2.28
52 Week Range1.98 - 4.33
Volume131,501
Avg. Volume213,180
Market Cap93.86M
Beta1.32
PE Ratio (TTM)-2.12
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Endocyte, Inc. :ECYT-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017
    Capital Cube4 days ago

    Endocyte, Inc. :ECYT-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017

    Categories: Yahoo Finance Get free summary analysis Endocyte, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Endocyte, Inc. – Amgen Inc., Johnson & Johnson, Merck & Co., Inc., General Electric Company, AbbVie, Inc. and Nektar Therapeutics (AMGN-US, JNJ-US, MRK-US, GE-US, ABBV-US and NKTR-US) that have ... Read more (Read more...)

  • Zacks9 days ago

    5 Cheap Breakout Stocks for Superb Returns

    The technique identifies those stocks whose prices are fluctuating within a specific band.

  • Endocyte, Inc. :ECYT-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017
    Capital Cube10 days ago

    Endocyte, Inc. :ECYT-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017

    Categories: Yahoo Finance Get free summary analysis Endocyte, Inc. reports financial results for the year ended December 31, 2016. We analyze the earnings along side the following peers of Endocyte, Inc. – Amgen Inc., Johnson & Johnson, Merck & Co., Inc., General Electric Company, AbbVie, Inc. and Nektar Therapeutics (AMGN-US, JNJ-US, MRK-US, GE-US, ABBV-US and NKTR-US) that have ... Read more (Read more...)